Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Moderna Inc. buy WatchMen

Start price
€97.01
24.03.24 / 50%
Target price
€130.00
24.03.25
Performance (%)
7.37%
Price
€104.16
29.04.24
Summary
This prediction is currently active. The BUY prediction by WatchMen shows slight gains of 7.37%. This prediction currently runs until 24.03.25. The prediction end date can be changed by WatchMen at any time. WatchMen has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Moderna Inc. 6.188% 6.188%
iShares Core DAX® 0.961% -2.210%
iShares Nasdaq 100 2.626% -1.918%
iShares Nikkei 225® 0.217% -7.216%
iShares S&P 500 1.540% -1.858%

According to WatchMen what are the pros and cons of Moderna Inc. for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
Undervalued
High dividend yield expected
positive Cash Flow expected
Good rating
Standard Investments for future growth
Valuable balance sheet
ROE higher than 10% per year
Normal challenges to pay loans and raise capital
Capable Management
Good culture
Innovative
Some uniques
Differentiated customer and product portfolio
Growths faster than the competition
Sustainability is important
Stable Large shareholder and/or long term investor
Small Risks for its business
Market Leader or Top 3
Small cyclical dependencies
Well known brand
Very Future proof/growth oriented business model
Cons

Comments by WatchMen for this prediction

In the thread Moderna Inc. diskutieren

Buy Moderna Inc.

Prediction Buy
Perf. (%) 7.37%
Target price 130.000
Change
Ends at

Kursziel gesetzt auf 130,0

Stopped prediction by WatchMen for Moderna Inc.

Moderna Inc.

Start price
Target price
Perf. (%)
€126.14
21.02.22
-
21.02.23
19.31%
22.02.23

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€91.45
25.11.20
€180.00
25.11.21
161.40%
26.11.21

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€104.16
16.11.20
-
16.11.21
-
16.11.20

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€80.67
16.11.20
-
16.11.21
0.36%
16.11.20

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected